Join Midwestern University faculty and students for a FREE 8-day hands-on workshop for Arionhigh school students to learn about healthcare professions. Apply Here.
Category Archives: AZBio News
Researchers develop new method to prevent prostate cancer chemoresistance
UArizona Cancer Center member Noel Warfel, PhD, co-led a research team that created and patented technology to combat anti-cancer drug resistance.Continue reading
SynCardia Systems LLC Announces Publication of Patent Application Covering Innovative Total Artificial Heart Design
Tucson, AZ, February 5th 2024 — SynCardia Systems, LLC., a Picard Medical Company, proudly announces that the U.S. Patent and Trademark Office (USPTO) has allowed claims of its groundbreaking patent application “Next Generation Total Artificial Heart” covering next generation total artificial heart designs.
The application describes novel technology aimed at eliminating external drive mechanisms by fully integrating the pumping mechanism within the implanted artificial heart ventricle. This new design represents a significant leap forward towards achieving a fully implantable system.Continue reading
The Flinn-Brown Fellowship application is open: Apply Now!
The Flinn-Brown Fellowship is a statewide civic leadership program like no other. Apply here now.Continue reading
Bill for Funding the Arizona Health Innovation Trust Fund Passes Senate Appropriations
SB1019: appropriation; health innovation trust fund received its first hearing in Arizona’s Senate Health and Human Services Committee on January 16, 2024 and passed with unanimous support. On January 30, 2024, the bill received a do pass recommendation from Senate Appropriation with a vote of 7 ayes, 2 nays and 1 not voting
As currently written, SB1019 appropriates $5M to the Arizona Health Innovation Trust Fund, and declares that it is the Legislature’s intent that the Fund, consisting of monies appropriated by the Legislature, gifts or grants donated or given to the Fund and earnings from the Fund, steadily grow to ultimately maintain a permanent endowment balance of at least $200 million. SB1019 is now is eligible for consideration by the Senate Rules Committee.Continue reading
C-Path Announces New Executive Directors for Duchenne Regulatory Science Consortium and T1D Consortium
Appointments of Seasoned Researchers Reinforce C-Path’s Leadership in Accelerating Innovative Therapy DevelopmentContinue reading
C-Path, ActiGraph, and University of Canberra Collaborate to Generate Evidence to Support Regulatory Qualification of Novel Digital Health Technology Measures in Chronic Heart Failure
Collaboration will generate evidence to contribute to FDA qualification of a patient-centered, accelerometer-based clinical outcome assessment in CHFContinue reading
AZBio Announces 2024 Officers and Directors
The Arizona Bioindustry Association, Inc. (AZBio) elected its 2024 officers at its January Board meeting. Continue reading
2024 is the Year the ASU Biodesign Institute Celebrates 20 Years of Nature-Inspired Innovation
Biodesign scientists have created a therapy against the Ebola virus, discovered an early diagnostic for breast cancer and provided data that brought potentially harmful chemicals in personal-care products to light.
These are just a handful of ways our research is leading to discoveries and inventions that answer today’s challenges. As the premier scientific research institute in the nation’s fastest-growing research university, Biodesign’s impact is accelerating. We invite you to explore highlights of our accomplishments and join us in designing a better future.Continue reading
C-Path Promotes Cécile Ollivier to Vice President of Global Affairs, Expanding Leadership in Drug Development
Ollivier to steer global strategic initiatives, reinforcing C-Path’s commitment to accelerating medical innovation and regulatory science.Continue reading